Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1008 of 3330
Next
>>
>
25176 to 25200 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MDA-MB-134-VI	HR+	Luminal	Everolimus	MTOR	MTOR	0.00427	uM	12206.164	0.7896	0.5735	0.9848
MDA-MB-134-VI	HR+	Luminal	Everolimus	MTOR	MTOR	0.0213	uM	12206.164	0.7201	0.4330	0.9848
MDA-MB-134-VI	HR+	Luminal	Everolimus	MTOR	MTOR	0.107	uM	12206.164	0.6404	0.2720	0.9848
MDA-MB-134-VI	HR+	Luminal	Everolimus	MTOR	MTOR	0.533	uM	12206.164	0.6528	0.2971	0.9848
MDA-MB-134-VI	HR+	Luminal	Everolimus	MTOR	MTOR	2.67	uM	12206.164	0.6077	0.2061	0.9848
MDA-MB-134-VI	HR+	Luminal	Everolimus	MTOR	MTOR	13.3	uM	12206.164	0.6036	0.1978	0.9848
MDA-MB-134-VI	HR+	Luminal	Everolimus	MTOR	MTOR	66.7	uM	12206.164	0.2027	-0.6044	0.9848
MDA-MB-157	TNBC	Basal B	Everolimus	MTOR	MTOR	0.000171	uM	12594.164	0.9890	0.9825	1.2567
MDA-MB-157	TNBC	Basal B	Everolimus	MTOR	MTOR	0.000853	uM	12594.164	0.9497	0.9195	1.2567
MDA-MB-157	TNBC	Basal B	Everolimus	MTOR	MTOR	0.00427	uM	12594.164	0.8976	0.8352	1.2567
MDA-MB-157	TNBC	Basal B	Everolimus	MTOR	MTOR	0.0213	uM	12594.164	0.8949	0.8308	1.2567
MDA-MB-157	TNBC	Basal B	Everolimus	MTOR	MTOR	0.107	uM	12594.164	0.8602	0.7742	1.2567
MDA-MB-157	TNBC	Basal B	Everolimus	MTOR	MTOR	0.533	uM	12594.164	0.8577	0.7700	1.2567
MDA-MB-157	TNBC	Basal B	Everolimus	MTOR	MTOR	2.67	uM	12594.164	0.8299	0.7242	1.2567
MDA-MB-157	TNBC	Basal B	Everolimus	MTOR	MTOR	13.3	uM	12594.164	0.8381	0.7378	1.2567
MDA-MB-157	TNBC	Basal B	Everolimus	MTOR	MTOR	66.7	uM	12594.164	0.7390	0.5722	1.2567
MDA-MB-175-VII	HR+	Luminal	Everolimus	MTOR	MTOR	0.000171	uM	12126.164	0.9555	0.8827	0.7532
MDA-MB-175-VII	HR+	Luminal	Everolimus	MTOR	MTOR	0.000853	uM	12126.164	0.8738	0.6720	0.7532
MDA-MB-175-VII	HR+	Luminal	Everolimus	MTOR	MTOR	0.00427	uM	12126.164	0.9035	0.7478	0.7532
MDA-MB-175-VII	HR+	Luminal	Everolimus	MTOR	MTOR	0.0213	uM	12126.164	0.8885	0.7095	0.7532
MDA-MB-175-VII	HR+	Luminal	Everolimus	MTOR	MTOR	0.107	uM	12126.164	0.7970	0.4797	0.7532
MDA-MB-175-VII	HR+	Luminal	Everolimus	MTOR	MTOR	0.533	uM	12126.164	0.8231	0.5445	0.7532
MDA-MB-175-VII	HR+	Luminal	Everolimus	MTOR	MTOR	2.67	uM	12126.164	0.7955	0.4761	0.7532
MDA-MB-175-VII	HR+	Luminal	Everolimus	MTOR	MTOR	13.3	uM	12126.164	0.7880	0.4576	0.7532
MDA-MB-175-VII	HR+	Luminal	Everolimus	MTOR	MTOR	66.7	uM	12126.164	0.3841	-0.4386	0.7532

|<
<<
Previous
Page 1008 of 3330
Next
>>
>
25176 to 25200 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)